Phase 4Recruiting
Effects of Tirzepatide-Induced Weight Loss on Left Cardiac Structure and Function and Coronary Artery Lesions in Obese Patients: A Prospective Study
- Sponsor
- Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
- Enrollment
- 50 planned
- Conditions
- Obesity
- Interventions
- Subcutaneous Tirzepatide Treatment
- Ages
- adults
- Registry
- ChiCTR2600134544
Full record on the Chinese Clinical Trial RegistrySource: WHO ICTRP, processed October 19, 2026
Primary outcomes
- Change in Epicardial Adipose Tissue Volume;
History
Last registry update
Registered
Started